{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:13:45Z","timestamp":1776474825783,"version":"3.51.2"},"reference-count":45,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["NO1-AI95383"],"award-info":[{"award-number":["NO1-AI95383"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN266200700022C"],"award-info":[{"award-number":["HHSN266200700022C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:p>Therapeutic drug monitoring (TDM) of moxifloxacin is recommended to improve the response to tuberculosis treatment and reduce acquired drug resistance. Limited sampling strategies (LSSs) are able to reduce the burden of TDM by using a small number of appropriately timed samples to estimate the parameter of interest, the area under the concentration-time curve.<\/jats:p>","DOI":"10.1128\/aac.00384-19","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T13:15:22Z","timestamp":1561122922000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":24,"title":["Limited Sampling Strategies Using Linear Regression and the Bayesian Approach for Therapeutic Drug Monitoring of Moxifloxacin in Tuberculosis Patients"],"prefix":"10.1128","volume":"63","author":[{"given":"Simone H. J.","family":"van den Elsen","sequence":"first","affiliation":[{"name":"University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieke G. G.","family":"Sturkenboom","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onno W.","family":"Akkerman","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands"},{"name":"University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Manika","sequence":"additional","affiliation":[{"name":"Pulmonary Department, Respiratory Infections Unit, Aristotle University of Thessaloniki, G. Papanikolaou Hospital, Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis P.","family":"Kioumis","sequence":"additional","affiliation":[{"name":"Pulmonary Department, Respiratory Infections Unit, Aristotle University of Thessaloniki, G. Papanikolaou Hospital, Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tjip S.","family":"van der Werf","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands"},{"name":"University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tuberculosis Research Unit, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9002-7052","authenticated-orcid":false,"given":"Charles","family":"Peloquin","sequence":"additional","affiliation":[{"name":"Infectious Disease Pharmacokinetics Laboratory, College of Pharmacy, University of Florida, Gainesville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daan J.","family":"Touw","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Willem C.","family":"Alffenaar","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands"},{"name":"School of Pharmacy and Westmead Hospital, University of Sydney, Faculty of Medicine and Health, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","volume-title":"Global tuberculosis report 2018","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. 2018. Global tuberculosis report 2018. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_3_2","volume-title":"Rapid communication: key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR\/RR-TB)","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. 2018. Rapid communication: key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR\/RR-TB). World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_4_2","volume-title":"WHO treatment guidelines for drug-resistant tuberculosis: 2016 update","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. 2016. WHO treatment guidelines for drug-resistant tuberculosis: 2016 update. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_5_2","volume-title":"Guidelines for treatment of tuberculosis","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. 2010. Guidelines for treatment of tuberculosis, 4th ed. World Health Organization, Geneva, Switzerland.","edition":"4"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30078-X"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2006.01.002"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2014.153"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270008330984"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/428055"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/521894"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.968"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01621-06"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00414-06"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01036-07"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(01)90023-X"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.5.669"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/424849"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00176610"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.8.2.181"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.04.019"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31821b793c"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq091"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw376"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw677"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00173-2017"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00073213"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu1146"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2016.1162785"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31820f40f8"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0222-8"},{"key":"e_1_3_2_33_2","first-page":"979","article-title":"Effect of rifampicin and isoniazid on the steady-state pharmacokinetics of moxifloxacin","volume":"136","author":"Ramachandran G","year":"2012","unstructured":"Ramachandran G, Hemanth Kumar AK, Srinivasan R, Geetharani A, Sugirda P, Nandhakumar B, Nandini R, Tharani CB. 2012. Effect of rifampicin and isoniazid on the steady-state pharmacokinetics of moxifloxacin. Indian J Med Res 136:979\u2013984.","journal-title":"Indian J Med Res"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.14.0935"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342090-00003"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit352"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00962-16"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00341-15"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2015.06.008"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.01.017"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01092-18"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01253-08"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S79772"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.8.2060"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx004"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-006-9116-0"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1177\/0049124104268644"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00384-19","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00384-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:34:12Z","timestamp":1645479252000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00384-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1128\/AAC.00384-19"],"URL":"https:\/\/doi.org\/10.1128\/aac.00384-19","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"2019-02-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00384-19"}}